A Retrospective, Cross-sectional Hospital-based Study to Determine the Epidemiological, Clinical and Comorbidity Characteristics in Older Adults with Psoriasis
Table 5.
Studies describing systemic comorbidities andPsoriasis.
|
| Year |
Author |
Country |
Age grp(years) |
Hypertension |
Diabetes Mellitus type II |
Dyslipidemia |
Ischemic Heart Disease |
Metabolic syndrome |
|
|
| Psoriasis |
Control |
Psoriasis |
Control |
Psoriasis |
Control |
Psoriasis |
Control |
Psoriasis |
Control |
|
|
| 1985 |
Henseler et al.44 |
Germany |
N/A |
1.9 |
0.8 |
2.1 |
1.1 |
- |
- |
- |
- |
- |
- |
|
| 2002 |
Niemann et al.37 |
USA |
20-90 |
34.7 |
11.9 |
11.5 |
3.3 |
10.7 |
3.3 |
- |
- |
- |
- |
|
| 2006 |
Gelfand et al.35 |
USA |
31-63 |
14.7 |
11.9 |
4.4 |
3.3 |
4.6 |
3.3 |
1.8 |
1.4 |
- |
- |
|
| 2012 |
Mazlin et al.36 |
Malaysia |
> 18 |
33.2 |
- |
17.7 |
- |
17.8 |
- |
5.8 |
- |
- |
- |
|
| 2012 |
Fernandez-Torres et al.17 |
Spain |
> 65 |
55.7 |
- |
25.7 |
- |
29 |
- |
- |
- |
- |
- |
|
| 2015 |
Takshita et al.26 |
USA |
|
67.6 |
- |
32.4 |
- |
59.9 |
- |
23.5 |
- |
- |
- |
|
| 2016 |
Phan C et al.41 |
France |
48.7 avg |
26.1 |
- |
11 |
- |
27.5 |
- |
- |
- |
- |
- |
|
| 2018 |
Feldman et al.45 |
USA |
>20 |
39.7 |
33.7 |
15.5 |
13 |
38.7 |
33 |
10.7 |
8.7 |
- |
- |
|
| 2018 |
Kim et al.34 |
South Korea |
> 20 |
5 |
3.3 |
- |
- |
- |
- |
- |
- |
- |
- |
|
| 2020 |
Yildizhan et al.16 |
Turkey |
≥65 |
57.3 |
- |
33.7 |
- |
22.5 |
- |
22.5 |
- |
- |
- |
|
| 2020 |
Our study |
India |
> 60 |
49.6 |
53.1 |
22.8 |
37 |
25.8 |
2.3 |
10.4 |
8.8 |
17.8 |
5.2 |
|
|
|
